Abstract
Patients with early stage hepatocellular carcinoma have good prognosis and are treated
with curative intent. Although this cohort of patients is generally defined by limited
tumor burden, good liver function, and preserved functional status, there remains
utility in further stratification to optimize overall survival and limit post-operative
morbidity and mortality. Transplant, resection, ablation, transarterial radioembolization,
and transarterial chemoembolization, either as monotherapy or in combination, may
play a crucial role in treating this cohort of patients depending on a multitude of
factors. In this section, we review each treatment modality and provide general guidelines
for patient selection.
Keywords
Early stage hepatocellular carcinoma - transarterial radioembolization - transarterial
chemoembolization - radiation segmentectomy - radiation lobectomy
